• Home
  • Contact
  •  NL 
  • Login medewerkers
  • mijnUMCG

Publicaties 2011

Print 

Boonstra EA, de Boer MT, Sieders E, Peeters PM, de Jong KP, Slooff MJ, Porte RJ.
Risk factors for central bile duct injury complicating partial liver resection.
Br J Surg. 2012 Feb;99(2):256-62.

Op den Dries S, Sutton ME, Lisman T, Porte RJ.
Protection of bile ducts in liver transplantation: looking beyond ischemia.
Transplantation. 2011 Aug 27;92(4):373-9.

op den Dries S, Buis CI, Adelmeijer J, Van der Jagt EJ, Haagsma EB, Lisman T, Porte RJ.
The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.
Liver Int. 2011 Sep;31(8):1102-9.

Eguchi S, Soyama A, Mergental H, van den Berg AP, Scheenstra R, Porte RJ, Slooff MJ.
Honoring the contract with our patients: outcome after repeated re-transplantation of the liver.
Clin Transplant. 2011 Mar-Apr;25(2):E211-8.

Ten Hove WR, Korkmaz KS, op den Dries S, de Rooij BJ, van Hoek B, Porte RJ, van der Reijden JJ, Coenraad MJ, Dubbeld J, Hommes DW, Verspaget HW.
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation.
Liver Int. 2011 Sep;31(8):1110-7.

Janse M, Lamberts LE, Franke L, Raychaudhuri S, Ellinghaus E, Muri Boberg K, Melum E, Folseraas T, Schrumpf E, Bergquist A, Björnsson E, Fu J, Jan Westra H, Groen HJ, Fehrmann RS, Smolonska J, van den Berg LH, Ophoff RA, Porte RJ, Weismüller TJ, Wedemeyer J, Schramm C, Sterneck M, Günther R, Braun F, Vermeire S, Henckaerts L, Wijmenga C, Ponsioen CY, Schreiber S, Karlsen TH, Franke A, Weersma RK.
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
Hepatology. 2011 Jun;53(6):1977-85.

van Keimpema L, Nevens F, Adam R, Porte RJ, Fikatas P, Becker T, Kirkegaard P, Metselaar HJ, Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study.
Drenth JP; European Liver and Intestine Transplant Association.
Transpl Int. 2011 Dec;24(12):1239-45.

Khan AA, Chow EC, Porte RJ, Pang KS, Groothuis GM.
The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.
Toxicol In Vitro. 2011 Feb;25(1):80-90.

Kist A, Wakkie J, Madu M, Versteeg R, ten Berge J, Nikolic A, Nieuwenhuijs VB, Porte RJ, Padbury RT, Barritt GJ.
Rapamycin induces heme oxygenase-1 in liver but inhibits bile flow recovery after ischemia.
J Surg Res. 2012 Aug;176(2):468-75.

Lerut J, Mergental H, Kahn D, Albuquerque L, Marrero J, Vauthey JN, Porte RJ.
Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver.
Liver Transpl. 2011 Oct;17 Suppl 2:S90-7.

Lisman T, Leuvenink HG, Porte RJ, Ploeg RJ.
Activation of hemostasis in brain dead organ donors: an observational study.
J Thromb Haemost. 2011 Oct;9(10):1959-65.

Lisman T, Caldwell SH, Porte RJ.
Anemia as a potential contributor to bleeding in patients with liver disease - neglected but not forgotten.
J. Hepatol 2011, 54: 594-595.

Lisman T, Porte RJ.
Pitfalls in assessing platelet activation status in patients with liver disease.
Liver Int. 2012 Jul;32(6):1027.

Lisman T, Porte RJ.
Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities.
J Hepatol. 2011 Oct;55(4):950-1.

Lisman T, Platto M, Meijers JC, Haagsma EB, Colledan M, Porte RJ.
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver.
Blood. 2011 Feb 10;117(6):2070-2.

Lisman T, Porte RJ.
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.
Liver Int. 2011 Aug;31(7):1063.

Melum E, Franke A, Schramm C, Weismüller TJ, Gotthardt DN, Offner FA, Juran BD, Laerdahl JK, Labi V, Björnsson E, Weersma RK, Henckaerts L, Teufel A, Rust C, Ellinghaus E, Balschun T, Boberg KM, Ellinghaus D, Bergquist A, Sauer P, Ryu E, Hov JR, Wedemeyer J, Lindkvist B, Wittig M, Porte RJ, Holm K, Gieger C, Wichmann HE, Stokkers P, Ponsioen CY, Runz H, Stiehl A, Wijmenga C, Sterneck M, Vermeire S, Beuers U, Villunger A, Schrumpf E, Lazaridis KN, Manns MP, Schreiber S, Karlsen TH.
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
Nat Genet. 2011 Jan;43(1):17-9.

Pereboom IT, Adelmeijer J, van der Steege G, van den Berg AP, Lisman T, Porte RJ.
Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
Transplantation. 2011 Sep 15;92(5):587-93.

de Rooij BJ, van der Beek MT, van Hoek B, Vossen AC, Rogier Ten Hove W, Roos A, Schaapherder AF, Porte RJ, van der Reijden JJ, Coenraad MJ, Hommes DW, Verspaget HW.
Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation.
J Hepatol. 2011 Oct;55(4):800-7.

Ruys AT, Tanis PJ, Iris ND, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM.
Surgical treatment of renal cell cancer liver metastases: a population-based study.
Ann Surg Oncol. 2011 Jul;18(7):1932-8.

Sutton ME, op den Dries S, Koster MH, Lisman T, Gouw AS, Porte RJ.
Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment.
Liver Int. 2012 Apr;32(4):554-9.

Verdonk RC, Haagsma EB, Jongsma T, Porte RJ, Roozendaal C, van den Berg AP, Hepkema BG.
A prospective analysis of the natural course of donor chimerism including the natural killer cell fraction after liver transplantation.
Transplantation. 2011 Aug 27;92(4):e22-4.